Milbank LLP advised GoldenTree Asset Management as the sole lender in connection with a $150 million senior secured credit agreement for Kashiv BioSciences, LLC (“Kashiv BioSciences”).
Kashiv BioSciences is a vertically integrated biopharmaceutical company with numerous commercial and advanced clinical-stage assets. The $150 million credit facility supports Kashiv BioSciences in advancing its infrastructure, enabling it to pursue its research, development and manufacturing strategy in both the US and India. The new credit facility will also support working capital requirements, research and development and other business purposes.
The Milbank team was led by New York-based Global Leveraged Finance partner Spencer Pepper and associates Ian Tomesch and Iris Frangou.
